New inhaled drug shows promise for rare lung disease
Disease control
Completed
This study tested an inhaled medication called seralutinib in 390 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe and limits physical activity. The goal was to see if the drug improves how far patients can walk in six minu…
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC